Quantifying the impact of real-world evidence: the sacubitril/valsartan experience
Andrew J. Epstein, Morgan H. Persky, Saif S. Rathore
doi: https://doi.org/10.1101/2024.09.27.24314305
Andrew J. Epstein
aMedicus Economics, Milton, Massachusetts
PhD MPPMorgan H. Persky
aMedicus Economics, Milton, Massachusetts
Saif S. Rathore
bSandbar Life Sciences, Kankakee, Illinois
MD PhD MPHArticle usage
Posted October 06, 2024.
Quantifying the impact of real-world evidence: the sacubitril/valsartan experience
Andrew J. Epstein, Morgan H. Persky, Saif S. Rathore
medRxiv 2024.09.27.24314305; doi: https://doi.org/10.1101/2024.09.27.24314305
Subject Area
Subject Areas
- Addiction Medicine (386)
- Allergy and Immunology (701)
- Anesthesia (193)
- Cardiovascular Medicine (2859)
- Dermatology (244)
- Emergency Medicine (431)
- Epidemiology (12569)
- Forensic Medicine (10)
- Gastroenterology (807)
- Genetic and Genomic Medicine (4447)
- Geriatric Medicine (402)
- Health Economics (716)
- Health Informatics (2856)
- Health Policy (1050)
- Hematology (376)
- HIV/AIDS (893)
- Medical Education (415)
- Medical Ethics (114)
- Nephrology (464)
- Neurology (4201)
- Nursing (223)
- Nutrition (617)
- Oncology (2205)
- Ophthalmology (626)
- Orthopedics (254)
- Otolaryngology (319)
- Pain Medicine (269)
- Palliative Medicine (83)
- Pathology (488)
- Pediatrics (1172)
- Primary Care Research (483)
- Public and Global Health (6787)
- Radiology and Imaging (1494)
- Respiratory Medicine (902)
- Rheumatology (430)
- Sports Medicine (369)
- Surgery (473)
- Toxicology (57)
- Transplantation (202)
- Urology (174)